Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 71335-2040

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 71335-2040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

Chemical structure of esomeprazole magnesium showing the molecular arrangement with two esomeprazole units complexed with magnesium ion and three water molecules.*

FDA Label Image

Esmoprazolemagnesiumfigure2 (Esomeprazolemagnesiumfigure2)

A line graph showing percent maintenance over six months for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses, compared to a placebo. The x-axis represents months, and the y-axis shows percent maintained, illustrating differences in maintenance rates by dosage over time.*

FDA Label Image

Esmoprazolemagnesiumfigure3 (Esomeprazolemagnesiumfigure3)

A line graph showing percent maintained on the y-axis across months on the x-axis, comparing Esomeprazole Magnesium delayed-release capsules 40 mg and 10 mg to placebo. The graph includes four data lines representing two dosages of Esomeprazole Magnesium and placebo over a six-month period.*

FDA Label Image

Esomeprazolemagnesiumfigure4 (Esomeprazolemagnesiumfigure4)

A line graph depicting the percentage of patients symptom-free over 28 days for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The x-axis is labeled 'Diary Day' from 0 to 28, and the y-axis shows 'Percent of Patients Symptom-Free' ranging from 0 to 100. The 40 mg and 20 mg groups show higher symptom-free percentages than placebo throughout the period.*

FDA Label Image

Esomeprazolemagnesiumfigure5 (Esomeprazolemagnesiumfigure5)

A line graph comparing the percent of patients symptom-free over 28 diary days for two dosages of Esomeprazole Magnesium Delayed-Release Capsules (20 mg and 40 mg) and a placebo group. The x-axis represents diary days from 0 to 28, and the y-axis shows the percent of patients symptom-free ranging from 0 to 100.*

FDA Label Image

Camber (Camber)

FDA Label Image

Label (Lbl713352040)

Label for Esomeprazole Magnesium DR 40 mg capsule, delayed release, oral use. The label shows it is packed by Bryant Ranch Prepack in Burbank, CA. The package contains 90 capsules and compares to Nexium 40 mg Capsule by Hetero Labs Limited. The NDC on the label is 71335-2040-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.